More studies in understanding the role of EPO in bone in specific pathological conditions are warranted as patients with diseases associated with high circulating EPO such as thalassemia (Vichinsky, 1998), sickle cell disease (Sarrai et al., 2007), and polycythemia vera (Farmer et al., 2013) have debilitating bone conditions. Here, EPO is linked to thalassemia.